Dr. Kunimoto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1101 E Missouri Ave
Phoenix, AZ 85014Phone+1 602-222-2221Fax+1 602-266-2044- Is this information wrong?
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 2001 - 2004
Massachusetts General HospitalInternship, Internal Medicine, 1999 - 2000
Harvard Medical SchoolClass of 1999
Certifications & Licensure
HI State Medical License 2005 - 2026
AZ State Medical License 2006 - 2026
CA State Medical License 2015 - 2025
PA State Medical License 2001 - 2006
DE State Medical License 2002 - 2002- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus Start of enrollment: 2012 Nov 01
- Telescope Exchange Study Start of enrollment: 2017 Mar 22
- The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy Start of enrollment: 2019 Nov 15
Publications & Presentations
PubMed
- 8 citationsSafety and Efficacy of Intravitreal Risuteganib for Non-Exudative AMD: A Multicenter, Phase 2a, Randomized, Clinical Trial.David S. Boyer, Victor H. Gonzalez, Derek Y Kunimoto, Raj K Maturi, Richard H. Roe, Michael A Singer, Samantha Xavier, Julie Kornfield, Baruch D. Kuppermann, Hugo Quir...> ;Ophthalmic Surgery, Lasers & Imaging Retina. 2021 Jun 1
- 19 citationsTwo-Year Results of the Phase 3 Randomized Controlled Study of Abicipar in Neovascular Age-Related Macular Degeneration.Rahul N. Khurana, Derek Y Kunimoto, Young Hee Yoon, Charles C. Wykoff, Andrew Chang, Raj K. Maturi, Hansjürgen Agostini, Eric H Souied, David R. Chow, Andrew J. Lotery...> ;Ophthalmology. 2021 Jul 1
- 59 citationsEfficacy and Safety of Abicipar in Neovascular Age-Related Macular Degeneration: 52-Week Results of Phase 3 Randomized Controlled Study.Derek Y Kunimoto, Young Hee Yoon, Charles C. Wykoff, Andrew Chang, Rahul N. Khurana, Raj K. Maturi, Hansjürgen Agostini, Eric H Souied, David R. Chow, Andrew J. Lotery...> ;Ophthalmology. 2020 Apr 9
- Join now to see all
Authored Content
- Efficacy and Safety of Abicipar in Neovascular Age‐Related Macular Degeneration: 52-Week Results of Phase 3 Randomized Controlled StudyApril 2020
Press Mentions
Aviceda Therapeutics Announces Formation of Executive TeamJanuary 11th, 2021
Telescope Implanted in Eye Helps Thousands of Arizonans SeeNovember 7th, 2015
Professional Memberships
- Fellow
Hospital Affiliations
Banner Baywood Medical CenterMesa, Arizona
St. Joseph's Hospital and Medical CenterPhoenix, Arizona
HonorHealth Scottsdale Osborn Medical CenterScottsdale, Arizona
HonorHealth Scottsdale Shea Medical CenterScottsdale, Arizona
HonorHealth Scottsdale Thompson Peak Medical CenterScottsdale, Arizona
Phoenix Children'sPhoenix, Arizona
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
